Cipla tops drug overcharging dues with ₹3,576 crore; J&J, Ranbaxy among top five
The government regulates the prices of certain medicines to prevent companies from charging patients more than the permitted amount
The government regulates the prices of certain medicines to prevent companies from charging patients more than the permitted amount
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
